What is the appropriate Kcentra (four‑factor prothrombin complex concentrate) dose for a 61‑kg, 56‑year‑old male before surgery?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Kcentra Dosing for Preoperative Anticoagulation Reversal

For a 61 kg, 56-year-old male requiring urgent surgery, the Kcentra dose depends critically on the pre-procedure INR value: if INR is unknown or unavailable, administer 25 IU/kg (1,525 units Factor IX) along with 5 mg IV vitamin K; if INR is 2-<4, use 25 IU/kg (1,525 units); if INR is 4-6, use 35 IU/kg (2,135 units); if INR is >6, use 50 IU/kg (3,050 units). 1

Dosing Algorithm Based on INR

The FDA-approved Kcentra dosing is weight-based and INR-stratified 1:

For this 61 kg patient:

  • INR 2 to <4: 25 units/kg = 1,525 units Factor IX
  • INR 4 to 6: 35 units/kg = 2,135 units Factor IX
  • INR >6: 50 units/kg = 3,050 units Factor IX

When INR is Unavailable

If surgery must proceed immediately without INR results available, administer 25 IU/kg (1,525 units) with 5 mg IV vitamin K, proceed with surgery, and check INR within 30 minutes. If the hemostatic safety threshold (INR ≤1.5, or ≤1.2 for neurosurgery) is not met, consider supplementary dosing. 2

Essential Concurrent Management

Always administer vitamin K concurrently with Kcentra to maintain vitamin K-dependent clotting factor levels once Kcentra's effects diminish. 1 The 2024 ERAS Cardiac Society guidelines recommend Kcentra at 0.12 mL/kg/min IV titrated to goal INR for emergent DOAC reversal, though this patient's scenario involves preoperative VKA reversal. 3

Timing and Monitoring Considerations

  • Measure INR as close to dosing time as possible - coagulation factors may be unstable in patients requiring urgent procedures 1
  • Target INR ≤1.5 for most surgeries, ≤1.2 for intracranial neurosurgery or neuraxial procedures 2
  • Monitor INR within 30 minutes post-administration - clinical trials showed Kcentra decreased INR to ≤1.3 within 30 minutes in most subjects 1
  • Check INR before the procedure to confirm hemostatic safety threshold is achieved 2

Important Safety Considerations

Thrombotic Risk

This patient's underlying condition requiring anticoagulation creates inherent thrombotic risk. Weigh the benefits of VKA reversal against thromboembolic event risks, especially if there is history of recent thromboembolism (<3 months). 1 Kcentra was not studied in patients with thromboembolic events, MI, CVA, TIA, or unstable angina within 3 months prior. 1

Recent pharmacovigilance data (2.3 million infusions) showed TEE rates of approximately 1 per 9,963 standard infusions, with most cases having pre-existing thrombotic risk factors. 4

Repeat Dosing

Repeat dosing is not recommended - safety and effectiveness have not been established. 1 Less than 5% of patients require repeat doses with appropriate initial dosing. 5

Weight Considerations

At 61 kg, this patient is well below the 100 kg dosing cap. Do not use adjusted body weight - actual body weight dosing achieves superior INR reversal compared to adjusted weight strategies. 6 The 100 kg maximum dose cap only applies to patients exceeding that weight. 1

Clinical Context: Warfarin vs. DOAC

This dosing applies specifically to vitamin K antagonist (warfarin) reversal. If this patient is on a DOAC instead:

  • For Factor Xa inhibitors (apixaban, rivaroxaban, edoxaban): Consider andexanet alfa as first-line if available; if unavailable, use 4F-PCC 25-50 IU/kg 7, 8
  • For dabigatran: Use idarucizumab 5g IV as specific reversal agent 9

Practical Administration

After calculating the dose, reconstitute Kcentra with provided Sterile Water for Injection (20 mL for 500 U kit, 40 mL for 1000 U kit) using the Mix2Vial transfer system. 1 The actual potency per vial (stated on carton) varies from 20-31 Factor IX units/mL after reconstitution, so verify the volume needed based on actual vial potency.

For this 61 kg patient requiring 1,525 units (at INR 2-<4), using a vial with 30 units/mL potency, administer approximately 51 mL.

References

Guideline

reversal of direct oral anticoagulants: guidance from the ssc of the isth.

Journal of Thrombosis and Haemostasis, 2024

Related Questions

What is the recommended dose of 4‑factor prothrombin complex concentrate (PCC) for reversing a supratherapeutic INR in an adult?
How can I safely bridge a patient who has stopped warfarin for a colonoscopy using four‑factor prothrombin complex concentrate (PCC)?
What is the recommended dose and administration of four‑factor prothrombin complex concentrate (Octaplex) for reversal of apixaban in patients with major bleeding or requiring urgent invasive procedures?
What is 4 factor Prothrombin Complex Concentrate (4F-PCC)?
What is Kcentra (prothrombin complex concentrate)?
In a 69-year-old patient with persistent left-sided neck pain, night-time stiffness, and a ratcheting sensation after a cervical sprain treated with prednisone and muscle relaxants, should cervical spine X-rays and MRI be obtained now, and what is the recommended medication taper and physical‑therapy plan?
In a person without celiac disease or dairy allergy, does eliminating gluten and dairy from the diet promote intestinal healing?
Is there a more portable, wrist‑worn ECG device that can be carried like a watch instead of the bulkier Kardia‑6L?
What are the appropriate next steps for managing a 45-year-old male with type 2 diabetes mellitus, BMI approximately 30, currently on weekly injectable semaglutide (1 mg), metformin (1 g daily), and glimepiride (1 mg daily) who developed epigastric discomfort, diarrhea, and nausea after the first 1‑mg semaglutide dose, given that the dose has been held and serum lipase, serum amylase, complete blood count, C‑reactive protein, and an in‑person evaluation have been ordered?
Can I take celecoxib (Celebrex) with prednisolone?
What is the recommended pain management plan for an adult with burn‑related pain and no contraindications?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.